5-161847421-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000638112.1(GABRA1):c.-293C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000638112.1 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 19Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- epilepsy, idiopathic generalized, susceptibility to, 13Inheritance: AD Classification: STRONG Submitted by: G2P
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- juvenile myoclonic epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA1 | ENST00000023897.10 | c.-248+10C>T | intron_variant | Intron 1 of 10 | 1 | ENSP00000023897.6 | ||||
GABRA1 | ENST00000638112.1 | c.-293C>T | 5_prime_UTR_variant | Exon 1 of 11 | 5 | ENSP00000489839.1 | ||||
ENSG00000294143 | ENST00000721460.1 | n.71+3099G>A | intron_variant | Intron 1 of 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at